TALPHERA, INC. — Director's Dealing 2014

Mar 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2014-03-02

Reporting Person: KING RICHARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-02	Common Stock	F	11599	$11.43	Disposed	134567	Direct

Footnotes

F1: The Shares were withheld to satisfy tax liability upon vesting 25% of the restricted stock units of the Company previously reported on March 4, 2011.

F2: Balance includes non-reportable acquisition of 19,209 shares of Common Stock through the Company's Employee Stock Purchase Plan.